Trial Profile
A Phase III, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group, Multicenter Evaluation of Civamide Nasal Solution 0.01% in the Prevention of Cluster Headaches During an Episodic Cluster Headache Period.
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2021
Price :
$35
*
At a glance
- Drugs Zucapsaicin (Primary)
- Indications Cluster headache
- Focus Therapeutic Use
- Sponsors Winston Laboratories
- 22 Apr 2021 Planned End Date changed from 1 Feb 2024 to 1 Feb 2026.
- 22 Apr 2021 Planned primary completion date changed from 1 Nov 2023 to 1 Nov 2025.
- 22 Apr 2021 Planned initiation date changed from 1 Nov 2021 to 1 Nov 2023.